openPR Logo
Press release

Liver Fibrosis Market to Reach USD 4.86 Billion by 2034

06-18-2025 12:02 PM CET | Health & Medicine

Press release from: Expert Market Research

According to Expert Market Research, the global liver fibrosis market is witnessing a steady rise, driven by increased disease burden, early diagnosis advancements, and a surge in clinical research around targeted therapies. As liver fibrosis progresses silently and often undiagnosed until later stages, the demand for innovative diagnostic tools and treatment options is rapidly growing.

Liver Fibrosis Market Size

In 2024, the liver fibrosis market was valued at USD 2,317.70 million, fueled by a rise in chronic liver conditions such as nonalcoholic steatohepatitis (NASH), hepatitis C, and alcohol-related liver disease. Growing public health awareness and improved screening protocols have significantly contributed to early detection.

Looking ahead, the market is projected to expand at a CAGR of 7.70% from 2025 to 2034, reaching approximately USD 4,866.47 million by 2034. The increasing burden of lifestyle-related diseases and an aging population are key contributors to this anticipated growth.

Get a Free Sample Report with Table of Contents - https://bitl.to/4iLJ.

Liver Fibrosis Market Share

North America, particularly the United States, currently holds a dominant share in the global liver fibrosis market, driven by strong research infrastructure, high awareness, and availability of advanced diagnostics. The 7MM regions-including the U.S., U.K., Germany, France, Italy, Spain, and Japan-together account for a significant portion of the market, thanks to increased healthcare expenditure and clinical trial activity.

In terms of condition-specific share, nonalcoholic steatohepatitis (NASH) is gaining momentum due to its growing prevalence in populations affected by obesity and metabolic syndrome. Meanwhile, chronic liver disease and hepatitis C remain primary contributors to disease burden and market opportunity.

Liver Fibrosis Market Growth & Trends

Several key trends are shaping the future of the liver fibrosis market:

Rise in NASH Cases: As obesity and type 2 diabetes cases surge globally, NASH-related liver fibrosis is becoming a leading concern. Pharmaceutical companies are investing heavily in novel therapeutic options targeting NASH progression.

Technological Advancements: Imaging technologies like elastography and fibro-scans are enabling non-invasive liver fibrosis assessment, reducing the dependency on biopsies.

Personalized Medicine: The development of biomarker-based therapies and gene-specific interventions is transforming treatment pathways and improving clinical outcomes.

Regulatory Support: Fast-track designations from regulatory agencies are accelerating the development of new liver fibrosis therapies.

For readers seeking a broader understanding of liver fibrosis as a medical condition, the Wikipedia page on liver fibrosis offers a helpful overview of the disease's causes and progression.

Read the Full Report with the Table of Contents - https://bitl.to/4iLH.

Liver Fibrosis Market Case Studies & News

Recent developments across the industry underscore the dynamic nature of this market:

FibroGen, Inc. has been at the forefront with its research into anti-fibrotic therapies targeting pro-fibrotic signaling pathways.

Gilead Sciences and Intercept Pharmaceuticals have invested in NASH-focused pipeline candidates aimed at halting or reversing liver scarring.

Johnson & Johnson and Merck & Co. are exploring combination therapies that integrate fibrosis-reducing agents with anti-inflammatory drugs.

Pharmaxis has advanced clinical trials for lysyl oxidase inhibitors (LOX) that show promise in fibrosis treatment.

Liver Fibrosis Market Analysis

Competitive Landscape:
The liver fibrosis market is marked by intense R&D activity, especially in the area of antifibrotic drugs. Major pharmaceutical firms are either developing proprietary molecules or forming strategic alliances to strengthen their pipelines.

Regional Insights:

The United States leads in clinical trials, investment, and adoption of advanced diagnostics.

Japan: With its aging population and high healthcare standards, it's a significant market for fibrosis detection and care.

Europe: Countries like Germany and France are progressing through well-structured public health programs focused on liver health and preventive care.

Regulatory Dynamics:
Agencies like the U.S. FDA and EMA are increasingly offering accelerated approval paths and orphan drug designations to encourage innovation in fibrosis therapeutics. This is encouraging smaller biotech firms to enter the market with targeted solutions.

Liver Fibrosis Market Segmentation

By Condition:

Chronic Liver Diseases

Hepatitis C

Nonalcoholic Steatohepatitis (NASH)

By Treatment Type:

Peroxisome Proliferator-Activated Receptors (PPAR)-alpha Agonist

ACE Inhibitors

Hepatotropic Drugs

Others

By Distribution Channel:

Hospital Pharmacies

Retail Stores and Pharmacies

Online Providers

By End User:

Hospitals

Clinics

Others

By Region (7MM):

United States

United Kingdom

Germany

France

Italy

Spain

Japan

Liver Fibrosis Market Key Players

Several leading pharmaceutical and biotechnology companies are shaping the liver fibrosis landscape:

F. Hoffmann-La Roche

Mylan N.V.

Sanofi

GlaxoSmithKline plc

AstraZeneca

Johnson & Johnson

Merck & Co.

Bristol-Myers Squibb

Vertex Pharmaceuticals

FibroGen, Inc.

Pharmaxis

Dicerna Pharmaceuticals, Inc.

Dynavax Technologies

These players are involved in diverse initiatives ranging from molecular research to clinical trial collaborations and market expansion strategies.

Uncover More Reports

Genomics Market - https://bitl.to/4eQQ

Legal Marijuana Market - https://bitl.to/4IdS

United States Medical Adhesives Market - https://linkd.so/3CsB

Ataxia Market - https://linkd.so/3CsC

Media Contact

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liver Fibrosis Market to Reach USD 4.86 Billion by 2034 here

News-ID: 4072086 • Views:

More Releases from Expert Market Research

Global Industrial Fasteners Market: Growth Outlook for 2026-2035
Global Industrial Fasteners Market: Growth Outlook for 2026-2035
Market Overview In 2025, the global industrial fasteners market is valued at approximately USD 97.13 billion. Industrial fasteners, which include bolts, nuts, rivets, screws, washers, and other components, are essential for joining two or more materials securely, making them indispensable in construction, automotive, aerospace, and machinery industries. As industrial sectors grow and demand for robust and reliable fastening solutions increases, the global market for these essential components is set to continue
Water Soluble Fertilizers Market Size, Trends & Forecast 2026-2035
Water Soluble Fertilizers Market Size, Trends & Forecast 2026-2035
The water soluble fertilizers market plays a vital role in the agriculture sector, catering to the growing need for efficient and sustainable farming practices. Water soluble fertilizers (WSFs) are fertilizers that are fully soluble in water and can be applied through irrigation systems, allowing for optimal nutrient absorption by plants. These fertilizers offer significant advantages, including uniform nutrient distribution, higher efficiency, and reduced environmental impact, making them increasingly popular in
IT Spending Market Outlook 2026-2035: Growth Drivers and Future Trends
IT Spending Market Outlook 2026-2035: Growth Drivers and Future Trends
The global IT spending market continues to expand steadily as enterprises across industries accelerate digital transformation, cloud migration, and artificial intelligence adoption. In 2025, the IT spending market attained a total value of USD 4.02 Trillion, reflecting strong global demand for software, IT services, cloud infrastructure, and communications technologies. The industry is expected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period of 2026-2035,
United States School Bus Market Size, Share & Forecast 2026-2035
United States School Bus Market Size, Share & Forecast 2026-2035
The United States school bus market is a crucial component of the country's transportation infrastructure, ensuring the safe and reliable transport of millions of students each day. With a history of being a significant mode of student transportation, school buses are now evolving with advancements in technology, safety, and environmental standards. As the demand for greener solutions and enhanced safety features grows, the U.S. school bus market is expanding to

All 5 Releases


More Releases for Liver

Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Liver Metastases Treatment Market Size By 2025? The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health. ● Product Name - LivCare
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production